Mounjaro Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Tirzepatide

Indications/Uses

Adults w/ insufficiently controlled type 2 DM as an adjunct to diet & exercise; as monotherapy when metformin is considered inappropriate due to intolerance or CI; in addition to other medicinal products for diabetes.

Dosage/Direction for Use

SC Initially 2.5 mg once wkly, increase dose to 5 mg once wkly after 4 wk. May increase dose in 2.5 mg increments after a min of 4 wk on the current dose if needed. Maintenance dose: 5 mg, 10 mg or 15 mg. Max dose: 15 mg once wkly.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity.

MIMS Class

Antidiabetic Agents

ATC Classification

A10BX16 - tirzepatide ; Belongs to the class of other blood glucose lowering drugs excluding insulins. Used in the treatment of diabetes.

Regulatory Classification

POM

Presentation/Packing

Form

Mounjaro soln for inj 2.5 mg/0.5 mL

Packing/Price

1's

Form

Mounjaro soln for inj 5 mg/0.5 mL

Packing/Price

1's

Form

Mounjaro soln for inj 7.5 mg/0.5 mL

Packing/Price

1's

Form

Mounjaro soln for inj 10 mg/0.5 mL

Packing/Price

1's

Form

Mounjaro soln for inj 12.5 mg/0.5 mL

Packing/Price

1's

Form

Mounjaro soln for inj 15 mg/0.5 mL

Packing/Price

1's

Mounjaro

tirzepatide

Manufacturer:

Eli Lilly and Company